a substance being studied in the treatment of some types of cancer. ci-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. it is a type of tyrosine kinase inhibitor. also called canertinib and canertinib dihydrochloride.
![]()